Sarami I, Duffield AS, Sundaram S, Lin DI, Salib C, Hussein S, El Jamal S, Ghesani N, Cangut B, Petersen BE. An aggressive hematolymphoid neoplasm with homozygous SMARCB1 loss shows response to EZH2 inhibition. Haematologica 2025;110(11):2849-2854; https://doi.org/10.3324/haematol.2024.285776.